2月11日 - ** 生命科学公司Avantor AVTR.N股价盘前下跌12.2%至9.80美元
** 公司公布 (link) 第四季度调整后每股收益 22 美分，符合分析师的平均预期，根据LSEG汇编的数据。
** 公司公布第四季度销售额为 16.6 亿美元，分析师预计为 16.4 亿美元。
** 去年，激进投资者 Engine Capital 敦促 (link) AVTR 更新董事会成员，削减成本，甚至出售公司。
** 2025 年，AVTR 股价暴跌 45%。
(为便利非英文母语者，路透将其报导自动化翻译为数种其他语言。由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。)
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.